Stocks in Focus on February 17: Dr Reddy's, Telecom Stocks to Hero MotoCorp; here are the 5 Newsmakers of the Day
Dr Reddy’s: The US health regulator, the United States Food and Drug Administration (USFDA), has asked drug major Dr Reddy’s Laboratories to initiate voluntary action at its Duvvada facility in Andhra Pradesh. With regard to the audit of our Formulations Manufacturing Plant at Duvvada, Visakhapatnam, we would like to inform you that we have been notified by the USFDA, that the inspection classification of the above-referred facility is determined as Voluntary Action Initiated,” Dr Reddy’s Laboratories on Sunday said in a BSE filing. Last week, the audit of Dr Reddy's Formulations Srikakulam Plant (SEZ) Unit I, Andhra Pradesh, was completed with zero observation by the US FDA.
Key benchmark indices ended lower on Friday, February 14, 2020, dragged by weakness in banks stocks. , Photo: Pixabay